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Abstract
Introduction Persistent coma is a common finding after cardiac
arrest and has profound ethical and economic implications.
Evidence suggests that therapeutic hypothermia improves
neurological outcome in these patients. In this analysis, we
investigate whether therapeutic hypothermia influences the
length of intensive care unit (ICU) stay and ventilator time in
patients surviving out-of-hospital cardiac arrest.
Methods A prospective observational study with historical
controls was conducted at our medical ICU. Fifty-two
consecutive patients (median age 62.6 years, 43 males, 34
ventricular fibrillation) submitted to therapeutic hypothermia
after out-of-hospital cardiac arrest were included. They were
compared with a historical cohort (n = 74, median age 63.8
years, 53 males, 43 ventricular fibrillation) treated in the era prior
to hypothermia treatment. All patients received the same
standard of care. Neurological outcome was assessed using the
Pittsburgh cerebral performance category (CPC) score.
Univariate analyses and multiple regression models were used.
Results In survivors, therapeutic hypothermia and baseline
disease severity (Acute Physiology and Chronic Health
Evaluation II [APACHE II] score) were both found to significantly
influence ICU stay and ventilator time (all P < 0.01). ICU stay
was shorter in survivors receiving therapeutic hypothermia
(median 14 days [interquartile range (IQR) 8 to 26] versus 21
days [IQR 15 to 30] in the control group; P = 0.017). ICU length
of stay and time on ventilator were prolonged in patients with
CPC 3 or 4 compared with patients with CPC 1 or 2 (P = 0.003
and P  = 0.034, respectively). Kaplan-Meier analysis showed
improved probability for 1-year survival in the hypothermia group
compared with the controls (log-rank test P = 0.013).
Conclusion Therapeutic hypothermia was found to significantly
shorten ICU stay and time of mechanical ventilation in survivors
after out-of-hospital cardiac arrest. Moreover, profound
improvements in both neurological outcome and 1-year survival
were observed.
Introduction
Persistent coma is a common finding after cardiac arrest and
has profound ethical and economic implications. In a signifi-
cant proportion of patients, neurological status rather than
specific treatment of the underlying disease affects the out-
come after cardiac arrest [1]. Recent randomized controlled
trials have demonstrated that therapeutic hypothermia is highly
effective in improving the neurological outcome in patients
after cardiac arrest [2,3]. In 2003, the International Liaison
Committee on Resuscitation (ILCOR) recommended this
treatment for all comatose survivors of out-of-hospital cardiac
arrest due to ventricular fibrillation [4]. Although only a minority
of such patients are currently treated with therapeutic hypo-
thermia [5,6], recent efforts aim to implement therapeutic
hypothermia as a routine procedure in patients after cardiac
arrest [7].
The optimal method for controlled and safe application of ther-
apeutic hypothermia is still under debate [8,9]. For intravascu-
lar cooling devices as well as for device-controlled surface
APACHE II = Acute Physiology and Chronic Health Evaluation II; CI = confidence interval; CPC = cerebral performance category; CPR = cardiop-
ulmonary resuscitation; ICU = intensive care unit; ILCOR = International Liaison Committee on Resuscitation; IQR = interquartile range; LOS = length 
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cooling methods, the efficacy has been demonstrated in differ-
ent trials [10-13]. Of course, other cooling methods like
crushed-ice, towels pre-soaked in ice water, or simple cooling
blankets may be very effective as well but the temperature
range is more difficult to control [14,15]. For out-of-hospital
cooling, new devices and methods for fast induction of hypo-
thermia are of increasing importance [16,17]. However, using
advanced cooling methods, equipment, and manpower
required for the application of therapeutic hypothermia gener-
ates higher treatment costs. Length of intensive care unit stay
(ICU LOS) has been identified as a major determinant of total
treatment costs after survived cardiac arrest [18]. Therefore, it
was investigated whether therapeutic hypothermia influences
ICU LOS and time of mechanical ventilation in patients after
out-of-hospital cardiac arrest.
Materials and methods
The study protocol was approved by the local ethics commit-
tee on human research. The need for informed patient consent
was waived by the committee. We conducted our study in an
urban area with a two-tiered medical emergency system: basic
life support, including automated defibrillation, is offered by
ambulances, and advanced life support procedures were per-
formed by qualified emergency physicians at the mobile ICU.
All patients with cardiac arrest and return of spontaneous cir-
culation (ROSC) in the field were directly admitted to our med-
ical ICU (MICU). Pre-hospital cooling procedures were not
applied during the study period.
Between January 2006 and January 2007, a total of 52
patients were admitted to our MICU after out-of-hospital car-
diac arrest. All patients received therapeutic hypothermia
according to the current ILCOR recommendations. A histori-
cal control group in the era prior to hypothermia treatment was
identified in a cohort of 74 patients admitted to our MICU
between 2003 and 2005 after out-of-hospital cardiac arrest.
Detailed characteristics for all study patients are presented in
Table 1.
Therapeutic hypothermia was initiated after admission with an
intravenous infusion of cold saline (4°C, 1,000 to 1,500 mL
bolus) followed by surface cooling with commercially available
non-invasive devices (CritiCool®; MTRE, Yavne, Rehovot,
Israel, or ArcticSun2000®; Medivance, Inc., Louisville, CO,
USA). After the start of cooling, the target temperature of 33°C
was reached in a range of 180 to 300 minutes and maintained
for 24 hours. Re-warming was performed at a rate of 0.25°C
per hour. Intravenous sedation was induced in all patients by a
combination of midazolam (0.125 mg/kg per hour) and fenta-
nyl (0.002 mg/kg per hour) with dose adjustment as needed.
Patients undergoing hypothermia received muscle relaxation
with repetitive pancuronium (0.1 mg/kg) administration in
order to prevent shivering. All patients completed therapeutic
hypothermia without complications or overcooling. With the
exception of therapeutic hypothermia, there was no further dif-
ference in the standard of intensive care treatment between
the two groups. To discover early-onset infection and pneumo-
nia, laboratory markers of systemic inflammation (c-reactive
protein/leukocyte count) and radiological findings of pneumo-
nia in chest x-ray were analyzed on day 3. Neurological out-
come was assessed at the time of discharge from the ICU
according to the Pittsburgh cerebral performance category
(CPC) score [19]. CPC 1 and 2 were classified as a favorable
neurological outcome, whereas CPC 3 and 4 were regarded
as an unfavorable outcome.
The SPSS software (version 13.0; SPSS Inc., Chicago, IL,
USA) and R (version 2.4.1; The R Foundation for Statistical
Computing) were used for statistical analysis. Descriptive
parameters are presented as median and interquartile range
(IQR) (25th to 75th percentiles). Univariate analysis of differ-
ences between hypothermia patients and the control group
was performed by using the Mann-Whitney U test for non-par-
ametric unpaired data and the Fisher exact test for dichoto-
mous variables. Multiple regression analysis was used to
adjust for confounders and to analyze the association of one
dependent and several independent variables. The general lin-
ear start model includes all independent variables, whereas
the final model contains only predictive factors after using the
automatic method of stepwise backward selection. Survival
data were analyzed by the Kaplan-Meier method, and compar-
ison between groups was performed by the log-rank test.
Results
Univariate analysis
Results of univariate analysis of all patients (n = 126) are pre-
sented in Table 1. Concerning age (P = 0.776) and gender (P
= 0.221), no significant differences were observed between
patients in the hypothermia group and the control group. How-
ever, APACHE II (Acute Physiology and Chronic Health Eval-
uation II) score on admission was significantly lower in the
control group (P = 0.015). No significant differences were cal-
culated concerning the first documented rhythm (P = 0.523),
dosage of epinephrine during resuscitation (P = 0.106), and
time to ROSC (P = 0.230). Patients with initial ventricular
fibrillation were classified as primary shockable rhythm,
whereas patients with asystole and pulseless electrical activity
were classified as primary non-shockable rhythm.
Univariate analysis of ICU LOS for all patients (dead and alive)
showed no significant difference between the two groups (P
= 0.947). However, if only survivors were analyzed, ICU LOS
was significantly lower in the hypothermia group (median 14
days [IQR 8 to 26] versus 21 days [IQR 15 to 30]; P = 0.017)
(Figure 1). In contrast to this finding, there was no statistically
significant difference regarding ICU LOS in patients who died
during ICU stay (median 9 days [IQR 6 to 22] for the hypother-
mia group and 7 days [IQR 5 to 10] for the control group; P =
0.250).Available online http://ccforum.com/content/12/3/R78
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Table 1
Baseline characteristics of the patient population and results of the univariate analysis
Control Hypothermia P value
(n = 74) (n = 52)
Age, years 63.8 (52.8–72.0) 62.6 (50.7–71.4) 0.776
Gender
Female 21 (28.4) 9 (17.3) 0.221
Male 53 (71.6) 43 (82.7)
APACHE II score 25.0 (20.0–30.0) 30.5 (22.5–33.0) 0.015
Cardiac arrest
Shockable rhythm 43 (58.1) 34 (65.4) 0.523
Non-shockable rhythm 31 (41.9) 18 (34.6)
Cause of cardiac arrest
Acute myocardial infarction 47 (63.5) 31 (59.6)
Primary arrhythmia 12 (16.2) 13 (25)
Respiratory 12 (16.2) 8 (15.4)
Other 3 (4.1) 0
Bystander CPR
Yes 12 (16.2) 16 (30.8) 0.086
No 62 (83.8) 36 (69.2)
Time to ROSC, minutes 20 (18–25) 20 (14–22) 0.230
Total epinephrine dose, mg 3.0 (2.0–4.0) 2.75 (0.8–3.1) 0.106
Length of ICU stay, days
All patients 15 (7–26) 13 (8–26) 0.947
Non-survivors 7 (5–10) 9 (6–22) 0.259
Survivors 21 (15–30) 14 (8–26) 0.017
Time on ventilator, hours
All patients 217 (139–353) 220 (124–428) 1
Non-survivors 165 (104–210) 221 (133–365) 0.219
Survivors 328 (208–461) 219 (125–447) 0.113
Leukocytes at day 3,/nL 11.0 (8.7–13.6) 12.2 (8.3–14.1) 0.91
C-reactive protein at day 3, mg/dL 12.7 (7.5–16.0) 14.5 (8.7–21.1) 0.33
Radiological signs of pneumonia 8 (10.8) 10 (19.2) 0.205
CPC at ICU discharge
1 – good recovery 8 (10.8) 22 (42.3)
2 – moderate disability 9 (12.2) 10 (19.2)
3 – severe disability 3 (4.1) 2 (3.8)
4 – vegetative state 23 (31.1) 3 (5.8)
5 – death 31 (41.9) 15 (28.8)
CPC 1–2 versus 3–5
CPC 1–2 17 (23.0) 32 (61.5) <0.001Critical Care    Vol 12 No 3    Storm et al.
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Univariate analysis of ventilator time revealed no significant dif-
ference for all patients (P = 1). Median ventilator time was
lower in the subgroup of survivors treated with hypothermia,
although the difference was not statistically significant (219
hours [IQR 125 to 447] for the hypothermia group versus 328
hours [IQR 208 to 461] for the control group; P = 0.113) (Fig-
ure 1). Also, there was no statistically significant difference in
ventilator time in the subgroup of non-survivors (221 hours
[IQR 133 to 365] for the hypothermia group and 165 hours
[IQR 104 to 210] for the control group; P = 0.219).
C-reactive protein, leukocyte count, and radiological diagnosis
of early-onset pneumonia on day 3 were not statistically differ-
ent between the groups (Table 1). With regard to the neuro-
logical outcome, both ICU LOS and time on ventilator were
significantly longer in patients with a CPC 3 or 4 compared
with patients with CPC 1 or 2 (P = 0.003 for LOS and P =
0.034 for ventilator time) (Figure 2). Hypothermia treatment
was associated with significantly improved neurological out-
come assessed by CPC 1 or 2 versus 3 or 4 (P < 0.001). The
results of the univariate analysis are summarized in Table 1.
Multivariate analysis
As univariate analysis showed significant differences between
the hypothermia and the control group, an adjustment for con-
founders was performed. To this end, ICU LOS and respirator
time were analyzed with the multivariate regression model,
including gender, age, APACHE II score, bystander cardiopul-
monary resuscitation (CPR), time to ROSC, initial rhythm, and
mild therapeutic hypothermia treatment as independent fac-
tors. The final model for ICU LOS in the subgroup of survivors
identified a low APACHE II score (P = 0.006) and hypother-
mia treatment (P  = 0.004) as independent predictors of
shorter ICU LOS.
Likewise, multivariate analysis in the subgroup of survivors
identified APACHE II score (P  = 0.009) and hypothermia
treatment (P = 0.026) as independent predictors of shorter
CPC 3–5 57 (77.0) 20 (38.5)
Died during hospital stay
Yes 31 (41.9) 15 (28.8) 0.190
No 43 (58.1) 37 (71.2)
Data are presented as medians (25th and 75th percentiles) or as absolute numbers (relative frequencies). APACHE II, Acute Physiology and 
Chronic Health Evaluation II; CPC, cerebral performance category; CPR, cardiopulmonary resuscitation; ICU, intensive care unit; ROSC, return of 
spontaneous circulation.
Table 1 (Continued)
Baseline characteristics of the patient population and results of the univariate analysis
Figure 1
Intensive care unit (ICU) length of stay and time on ventilator in the study groups Intensive care unit (ICU) length of stay and time on ventilator in the study groups. Boxplot of ICU length of stay (left) and time on ventilator (right) in 
survivors of the hypothermia (n = 23) and the control (n = 43) group.Available online http://ccforum.com/content/12/3/R78
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time on mechanical ventilation. The complete results of the
multivariate analyses are presented in Table 2. Follow-up data
for 1-year survival probability were performed including all
patients (n = 126). Kaplan-Meier analysis revealed a probabil-
ity for 365-day survival of 55.1% (confidence interval [CI]
39.1% to 68.5%) in the hypothermia group compared with
30.8% (CI 19.9% to 42.3%) in the control group. The log-rank
test was significant (P = 0.013) (Figure 3).
Discussion
Mild therapeutic hypothermia is recommended by current
ILCOR guidelines and has become an essential part in post-
resuscitation care. Although the benefit concerning neurolog-
ical outcome could not be demonstrated in a few single cent-
ers, most other trials could show an improved neurological
outcome under hypothermia even in unselected effectiveness
trials [20,21]. Nevertheless, technical, logistical, and financial
barriers may limit the transfer into daily practice [22]. There-
fore, for the first time, the present study investigates the impact
of therapeutic hypothermia on ICU LOS in patients with out-of-
hospital cardiac arrest. The major determinants of short ICU
LOS and ventilator time in patients after cardiac arrest were
found to be either early death during ICU stay or rapid neuro-
logical recovery. While comparison of all patients (survivors
and non-survivors) did not reveal a statistical difference
regarding ICU LOS, subgroup analysis showed that short ICU
LOS is related to an improved neurological outcome in the
hypothermia group. In contrast, short ICU LOS in the control
group was associated with a high rate of non-survivors. This
striking result was confirmed with a multivariate regression
model emphasizing the impact of therapeutic hypothermia on
ICU LOS.
A high APACHE II score at admission was associated with a
prolonged ICU stay in our study. It seems plausible that
patients with higher severity of illness depend more on critical
care facilities; however, it is known that the predictive value of
the APACHE II score has various limitations after cardiac
arrest [23,24]. Our present results suggest that prognostic
application of current scoring systems may be even more diffi-
cult in patients treated with therapeutic hypothermia. Both ICU
LOS and time of mechanical ventilation tended to be longer in
non-survivors of the hypothermia group compared with non-
survivors of the control group, which may reflect the difficulty
of outcome prediction in patients routinely requiring sedation
and muscle relaxation in the first days of intensive care. Beside
clinical evaluation, biochemical markers (neuron-specific eno-
lase, protein S100B) and electrophysiological studies (soma-
tosensory-evoked potentials) are established tools for
outcome prediction in patients after cardiac arrest [25,26].
However, most of these parameters were studied in patients
not undergoing hypothermia treatment. At present, little data
on whether therapeutic hypothermia treatment may influence
these biomarkers are available [27,28]. Therefore, physicians
should be careful in the prognostication of patients treated
with therapeutic hypothermia [29].
It should be mentioned that our analysis has various limitations.
First of all, results obtained with an observational study design
using a historical control group generally require further valida-
tion by a randomized controlled trial. However, ethical con-
Figure 2
Intensive care unit (ICU) length of stay and time on ventilator and neurological outcome Intensive care unit (ICU) length of stay and time on ventilator and neurological outcome. Boxplot of ICU length of stay (left) and time on ventilator 
(right) of the study population (n = 126) according to the neurological outcome assessed as cerebral performance category (CPC).Critical Care    Vol 12 No 3    Storm et al.
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cerns will most likely prevent a further randomized trial that
withholds hypothermia treatment from a control group. Sec-
ond, our local treatment standards may have affected ICU
LOS and patient outcome. There is considerable variation
regarding end-of-life decisions and care practices. Thus, the
approach used by a specific ICU on deciding whether to with-
hold or withdraw critical care in patients after cardiac arrest
may have an important impact on ICU LOS. This may help to
explain data from a Canadian survey reporting that patients
with a higher Glasgow Coma Scale score had a longer ICU
stay [30].
Moreover, differences in ICU LOS may also be related to a dif-
ferent use and allocation of ICU capacities in general. Deci-
sion making potentially may be influenced by a variety of
factors that are independent of the individual patient charac-
teristics, such as the availability of ICU beds and/or of facilities
of 'step-down' care. It is of interest to note, however, that the
necessity of mechanical ventilation, which is a rather objective
criterion for the necessity of ICU treatment, is reduced by
hypothermia treatment. Since impaired neurological status has
been identified as a predictor of extubation failure or weaning
failure [31,32], this finding may be associated with the more
favorable neurological outcome in the hypothermia group.
Table 2
Multivariate analysis
Coefficient 5% CI 95% CI P value
Start model (ICU LOS)
(Intercept) 7.84 -17.32 33.01 0.543
Gender female -4.72 -14.12 4.67 0.328
Age 0.08 -0.19 0.36 0.553
APACHE II score 0.66 0.18 1.13 0.008
Hypothermia treatment -10.63 -17.93 -3.32 0.006
Bystander CPR -1.69 -9.57 6.20 0.676
Ventricular fibrillation 0.95 -6.71 8.61 0.809
Time to ROSC -0.12 -0.73 0.49 0.706
Final model (ICU LOS)
(Intercept) 10.80 -0.64 22.24 0.068
APACHE II score 0.63 0.19 1.07 0.006
Hypothermia treatment -10.66 -17.73 -3.59 0.004
Start model (time on ventilator)
(Intercept) 161.45 -409.67 732.58 0.581
Gender female 2.11 -212.22 216.44 0.985
Age 0.67 -5.40 6.74 0.830
APACHE II score 13.40 3.07 23.74 0.013
Hypothermia treatment -182.72 -342.75 -22.69 0.028
Bystander CPR -73.32 -245.39 98.75 0.407
Time to ROSC -5.16 -19.03 8.71 0.469
Ventricular fibrillation 22.19 -145.07 189.46 0.780
Final model (time on ventilator)
(Intercept) 107.25 -142.68 357.17 0.403
APACHE II score 13.07 3.58 22.57 0.009
Hypothermia treatment -179.41 -333.73 -25.09 0.026
Regression coefficients, associated confidence intervals, and P values of start multiple regression model and final model after stepwise backward 
selection. Sign (- or +) indicates negative or positive effect on the dependent variable. APACHE II, Acute Physiology and Chronic Health 
Evaluation II; CI, confidence interval; CPR, cardiopulmonary resuscitation; ICU LOS, intensive care unit length of stay; ROSC, return of 
spontaneous circulation.Available online http://ccforum.com/content/12/3/R78
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Another issue with impact on ICU LOS and time on ventilator
might be systemic inflammation after cardiac arrest. Both
infectious and non-infectious systemic inflammations are a fre-
quent problem in these patients [33,34]. As demonstrated in
the HACA (Hypothermia after Cardiac Arrest) trial, there may
even be a trend toward a higher rate of infections in patients
treated with therapeutic hypothermia. However, we found no
difference between the two study groups with respect to lab-
oratory markers of inflammation (C-reactive protein/leukocyte
count) and radiological findings of early-onset pneumonia.
Therefore, early infection or pneumonia had no impact on dif-
ferent mechanical ventilator times between the groups.
In our analysis, we may have suffered from a selection bias
because some baseline characteristics (bystander CPR and
rate of ventricular fibrillation) tended to be more favorable in
the hypothermia group although APACHE II score was lower
in the control group. Finally, we cannot exclude the fact that
the introduction of therapeutic hypothermia itself has focused
the attention of the physicians in charge to a more sophisti-
cated post-resuscitation care in general, which has been
described [35]. However, similar promising results were also
reported from a large hypothermia registry [36].
Conclusion
In summary, patients treated with therapeutic hypothermia
showed both an impressive improvement of neurological out-
come as well as an increased 1-year survival rate. Furthermore,
therapeutic hypothermia did not prolong ICU stay or time of
mechanical ventilation; rather, these parameters were reduced
in survivors when therapeutic hypothermia was applied.
Although we did not directly calculate the ICU treatment costs,
we believe that this could be an additional argument for the
application of therapeutic hypothermia in patients after cardiac
arrest.
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